Unnamed: 0
int64
0
1.41M
headline
stringlengths
3
513
url
stringlengths
33
162
publisher
stringlengths
3
46
date
timestamp[s]
stock
stringlengths
1
5
100
Top 10 Movers Via Benzinga Pro's Screener Tool For Morning of Friday., August 16, 2019
https://www.benzinga.com/trading-ideas/19/08/14284155/top-10-movers-via-benzinga-pros-screener-tool-for-morning-of-friday-august-16-2019
Benzinga Newsdesk
2019-08-16T00:00:00
A
101
75 Biggest Movers From Yesterday
https://www.benzinga.com/news/19/08/14282638/75-biggest-movers-from-yesterday
Lisa Levin
2019-08-16T00:00:00
A
102
46 Stocks Moving In Thursday's Mid-Day Session
https://www.benzinga.com/news/19/08/14278248/46-stocks-moving-in-thursdays-mid-day-session
Lisa Levin
2019-08-15T00:00:00
A
103
Agilent Technologies shares are trading higher after the company reported better-than-expected Q3 EPS and sales results. The company also issued FY19 EPS above analyst estimates.
https://www.benzinga.com/markets/wiim/19/08/14275943/agilent-technologies-shares-are-trading-higher-after-the-company-reported-better-than-expected-q3-ep
Benzinga Newsdesk
2019-08-15T00:00:00
A
104
A Peek Into The Markets: US Stock Futures Tumble Ahead Of Economic Data
https://www.benzinga.com/news/earnings/19/08/14273595/a-peek-into-the-markets-us-stock-futures-tumble-ahead-of-economic-data
Lisa Levin
2019-08-15T00:00:00
A
105
10 Stocks To Watch For August 15, 2019
https://www.benzinga.com/news/earnings/19/08/14273052/10-stocks-to-watch-for-august-15-2019
Lisa Levin
2019-08-15T00:00:00
A
106
Agilent Technologies shares are trading higher after the company reported better-than-expected Q3 EPS and sales results. The company also issued FY19 EPS above analyst estimates.
https://www.benzinga.com/markets/wiim/19/08/14270855/agilent-technologies-shares-are-trading-higher-after-the-company-reported-better-than-expected-q3-ep
Benzinga Newsdesk
2019-08-14T00:00:00
A
107
Agilent Technologies Sees Q4 Adj. EPS $0.84-$0.86 vs $0.87 Est., Sales $1.31B-$1.33B vs $1.34B Est., Sees FY19 Adj. EPS $3.07-$3.08 vs $3.05 Est., Sales $5.105B-$5.125B vs $5.11B Est.
https://www.benzinga.com/news/19/08/14270614/agilent-technologies-sees-q4-adj-eps-0-84-0-86-vs-0-87-est-sales-1-31b-1-33b-vs-1-34b-est-sees-fy19
Benzinga Newsdesk
2019-08-14T00:00:00
A
108
Agilent Technologies Q3 Adj. EPS $0.76 Beats $0.72 Estimate, Sales $1.27B Beat $1.24B Estimate
https://www.benzinga.com/news/earnings/19/08/14270569/agilent-technologies-q3-adj-eps-0-76-beats-0-72-estimate-sales-1-27b-beat-1-24b-estimate
Benzinga Newsdesk
2019-08-14T00:00:00
A
109
Q3 Earnings Preview For Agilent Technologies
https://www.benzinga.com/news/earnings-previews/19/08/14262424/earnings-preview-agilent-technologies
Benzinga Newsdesk
2019-08-14T00:00:00
A
110
Earnings Scheduled For August 14, 2019
https://www.benzinga.com/news/earnings/19/08/14262860/earnings-scheduled-for-august-14-2019
Lisa Levin
2019-08-14T00:00:00
A
111
Shares of diagnostics and research companies are trading higher in sympathy with Syneos Health, which reported strong Q2 results and raised FY19 guidance.
https://www.benzinga.com/markets/wiim/19/08/14212087/shares-of-diagnostics-and-research-companies-are-trading-higher-in-sympathy-with-syneos-health-which
Benzinga Newsdesk
2019-08-06T00:00:00
A
112
Shares of several gold companies are trading higher amid heightened US-China trade tensions. Concerns of a trade war have led investors into 'safe-haven' assets such as gold.
https://www.benzinga.com/markets/wiim/19/08/14200364/shares-of-several-gold-companies-are-trading-higher-amid-heightened-us-china-trade-tensions-concerns
Benzinga Newsdesk
2019-08-05T00:00:00
A
113
Agilent Announces Settlement of Key Intellectual Property Case in China
https://www.benzinga.com/news/19/08/14177141/agilent-announces-settlement-of-key-intellectual-property-case-in-china
Charles Gross
2019-08-01T00:00:00
A
114
Agilent Shares Unaffected As Hearing FDA Approved Co.'s PD-L1 IHC 22C3 PharmDx Assay For Expanded Use
https://www.benzinga.com/news/19/07/14172596/agilent-shares-unaffected-as-hearing-fda-approved-co-s-pd-l1-ihc-22c3-pharmdx-assay-for-expanded-use
Benzinga Newsdesk
2019-07-31T00:00:00
A
115
Benzinga Pro's Top 10 Most-Searched Tickers For Morning of Tuesday, July 16, 2019
https://www.benzinga.com/trading-ideas/19/07/14081534/benzinga-pros-top-10-most-searched-tickers-for-morning-of-tuesday-july-16-2019
Benzinga Newsdesk
2019-07-16T00:00:00
A
116
Benzinga's Top Upgrades, Downgrades For July 16, 2019
https://www.benzinga.com/analyst-ratings/upgrades/19/07/14080665/benzingas-top-upgrades-downgrades-for-july-16-2019
Lisa Levin
2019-07-16T00:00:00
A
117
Bank of America Downgrades Agilent Technologies to Neutral
https://www.benzinga.com/news/19/07/14079253/bank-of-america-downgrades-agilent-technologies-to-neutral
Benzinga_Newsdesk
2019-07-16T00:00:00
A
118
Barclays Downgrades Agilent Technologies to Equal-Weight, Lowers Price Target to $78
https://www.benzinga.com/news/19/07/14071989/barclays-downgrades-agilent-technologies-to-equal-weight-lowers-price-target-to-78
Vick Meyer
2019-07-15T00:00:00
A
119
Agilent Will Acquire BioTek Instruments In $1.16B Deal
https://www.benzinga.com/general/biotech/19/07/14059736/agilent-will-acquire-biotek-instruments-in-1-16b-deal
Tanzeel Akhtar
2019-07-11T00:00:00
A
120
Agilent To Purchase BioTek Instruments For $1.165B
https://www.benzinga.com/m-a/19/07/14059585/agilent-to-purchase-biotek-instruments-for-1-165b
Benzinga Newsdesk
2019-07-11T00:00:00
A
121
Benzinga's Top Upgrades, Downgrades For June 11, 2019
https://www.benzinga.com/analyst-ratings/upgrades/19/06/13902075/benzingas-top-upgrades-downgrades-for-june-11-2019
Lisa Levin
2019-06-11T00:00:00
A
122
Agilent Companion Diagnostic Receives Expanded FDA Approval For PD-L1 IHC 22C3 PharmDx
https://www.benzinga.com/news/19/06/13900892/agilent-companion-diagnostic-receives-expanded-fda-approval-for-pd-l1-ihc-22c3-pharmdx
Benzinga Newsdesk
2019-06-11T00:00:00
A
123
Piper Jaffray Initiates Coverage On Agilent Technologies with Overweight Rating, Announces $83 Price Target
https://www.benzinga.com/news/19/06/13900616/piper-jaffray-initiates-coverage-on-agilent-technologies-with-overweight-rating-announces-83-price-t
Vick Meyer
2019-06-11T00:00:00
A
124
Shares of many Healthcare companies are trading higher as markets rebound from the recent volatility caused by uncertainty regarding US-China trade talks. Also, lawmakers were not able to pass a bill that would end 'surprise medical bills'.
https://www.benzinga.com/markets/wiim/19/05/13759342/shares-of-many-healthcare-companies-are-trading-higher-as-markets-rebound-from-the-recent-volatility
Benzinga Newsdesk
2019-05-16T00:00:00
A
125
60 Biggest Movers From Yesterday
https://www.benzinga.com/news/19/05/13753926/60-biggest-movers-from-yesterday
Lisa Levin
2019-05-16T00:00:00
A
126
44 Stocks Moving In Wednesday's Mid-Day Session
https://www.benzinga.com/news/19/05/13747598/44-stocks-moving-in-wednesdays-mid-day-session
Lisa Levin
2019-05-15T00:00:00
A
127
Benzinga Pro's Top 10 Most-Searched Tickers For Morning of Wed., May 15, 2019
https://www.benzinga.com/news/19/05/13745323/benzinga-pros-top-10-most-searched-tickers-for-morning-of-wed-may-15-2019
Benzinga Newsdesk
2019-05-15T00:00:00
A
128
Bank of America Maintains Buy on Agilent Technologies, Inc. Common Stock, Lowers Price Target to $82
https://www.benzinga.com/news/19/05/13744668/bank-of-america-maintains-buy-on-agilent-technologies-inc-common-stock-lowers-price-target-to-82
Vick Meyer
2019-05-15T00:00:00
A
129
Agilent Technologies shares are trading lower after the company reported worse-than-expected Q2 EPS and sales results; the company also announced weak Q3 sales guidance.
https://www.benzinga.com/markets/wiim/19/05/13744580/agilent-technologies-shares-are-trading-lower-after-the-company-reported-worse-than-expected-q2-eps
Benzinga  Newsdesk
2019-05-15T00:00:00
A
130
Deutsche Bank Maintains Buy on Agilent Technologies, Inc. Common Stock, Lowers Price Target to $85
https://www.benzinga.com/news/19/05/13744046/deutsche-bank-maintains-buy-on-agilent-technologies-inc-common-stock-lowers-price-target-to-85
Vick Meyer
2019-05-15T00:00:00
A
131
Barclays Maintains Overweight on Agilent Technologies, Inc. Common Stock, Lowers Price Target to $86
https://www.benzinga.com/news/19/05/13743833/barclays-maintains-overweight-on-agilent-technologies-inc-common-stock-lowers-price-target-to-86
Vick Meyer
2019-05-15T00:00:00
A
132
A Peek Into The Markets: US Stock Futures Down Ahead Of Macy's Earnings, Economic Data
https://www.benzinga.com/news/19/05/13742789/a-peek-into-the-markets-us-stock-futures-down-ahead-of-macys-earnings-economic-data
Lisa Levin
2019-05-15T00:00:00
A
133
8 Stocks To Watch For May 15, 2019
https://www.benzinga.com/news/earnings/19/05/13741913/8-stocks-to-watch-for-may-15-2019
Lisa Levin
2019-05-15T00:00:00
A
134
5 Stocks Moving In Tuesday's After-Hours Session
https://www.benzinga.com/news/19/05/13739717/5-stocks-moving-in-tuesdays-after-hours-session
Brett Hershman
2019-05-14T00:00:00
A
135
Agilent Technologies shares are trading lower after the company reported worse-than-expected Q2 EPS and sales results; the company also issued Q3 sales guidance below analyst estimates.
https://www.benzinga.com/markets/wiim/19/05/13738494/agilent-technologies-shares-are-trading-lower-after-the-company-reported-worse-than-expected-q2-eps
Hal Lindon
2019-05-14T00:00:00
A
136
Agilent Technologies Sees Q3 Adj. EPS $0.71-$0.73 vs $0.73 Est., Sales $1.225B-$1.245B vs $1.27B Est. Sees FY19 Adj. EPS $3.03-$3.07 vs $3.07 Est., Sales $5.085B-$5.125B vs $5.19B Est.
https://www.benzinga.com/news/19/05/13738472/agilent-technologies-sees-q3-adj-eps-0-71-0-73-vs-0-73-est-sales-1-225b-1-245b-vs-1-27b-est-sees-fy1
Benzinga Newsdesk
2019-05-14T00:00:00
A
137
Agilent Technologies Q2 Adj. EPS $0.71 Misses $0.72 Estimate, Sales $1.24B Miss $1.27B Estimate
https://www.benzinga.com/news/earnings/19/05/13738449/agilent-technologies-q2-adj-eps-0-71-misses-0-72-estimate-sales-1-24b-miss-1-27b-estimate
Benzinga Newsdesk
2019-05-14T00:00:00
A
138
Shares of several healthcare companies are trading higher as the US market rebounds from recent weakness, driven by renewed cautious optimism surrounding US-China trade talks.
https://www.benzinga.com/markets/wiim/19/05/13736459/shares-of-several-healthcare-companies-are-trading-higher-as-the-us-market-rebounds-from-recent-weak
Benzinga Newsdesk
2019-05-14T00:00:00
A
139
6 Stocks To Watch For May 14, 2019
https://www.benzinga.com/news/earnings/19/05/13731379/6-stocks-to-watch-for-may-14-2019
Lisa Levin
2019-05-14T00:00:00
A
140
Earnings Scheduled For May 14, 2019
https://www.benzinga.com/news/earnings/19/05/13731335/earnings-scheduled-for-may-14-2019
Lisa Levin
2019-05-14T00:00:00
A
141
Shares of several healthcare companies are trading lower in sympathy with the overall market. The S&P 500 is trading lower 1%
https://www.benzinga.com/markets/wiim/19/05/13717298/shares-of-several-healthcare-companies-are-trading-lower-in-sympathy-with-the-overall-market-the-s-p
Benzinga Newsdesk
2019-05-10T00:00:00
A
142
10 Biggest Price Target Changes For Tuesday
https://www.benzinga.com/analyst-ratings/price-target/19/03/13424112/10-biggest-price-target-changes-for-tuesday
Lisa Levin
2019-03-26T00:00:00
A
143
Cowen & Co. Maintains Outperform on Agilent Technologies, Raises Price Target to $90
https://www.benzinga.com/news/19/03/13422582/cowen-co-maintains-outperform-on-agilent-technologies-raises-price-target-to-90
Vick Meyer
2019-03-26T00:00:00
A
144
Benzinga's Top Upgrades, Downgrades For March 15, 2019
https://www.benzinga.com/analyst-ratings/upgrades/19/03/13367957/benzingas-top-upgrades-downgrades-for-march-15-2019
Lisa Levin
2019-03-15T00:00:00
A
145
UBS Initiates Coverage On Agilent Technologies with Buy Rating, Announces $92 Price Target
https://www.benzinga.com/news/19/03/13367090/ubs-initiates-coverage-on-agilent-technologies-with-buy-rating-announces-92-pric
Vick Meyer
2019-03-15T00:00:00
A
146
Barclays Maintains Overweight on Agilent Technologies, Raises Price Target to $83
https://www.benzinga.com/news/19/02/13217736/barclays-maintains-overweight-on-agilent-technologies-raises-price-target-to-83
Vick Meyer
2019-02-21T00:00:00
A
147
UPDATE: Agilent Raises FY19 Adj. EPS Guidance From $3-$3.05 To $3.03-$3.07 vs $3.05 Estimate, Sales From $5.13B-$5.17B To $5.15B-$5.19B vs $5.17B Est.
https://www.benzinga.com/news/19/02/13212634/update-agilent-raises-fy19-adj-eps-guidance-from-3-3-05-to-3-03-3-07-vs-3-05-est
Benzinga Newsdesk
2019-02-20T00:00:00
A
148
Agilent Sees Q2 Adj. EPS $0.70-$0.72 vs $0.72 Estimate, Sales $1.255B-$1.27B vs $1.27B Est.; Raises FY19 Guidance
https://www.benzinga.com/news/19/02/13212621/agilent-sees-q2-adj-eps-0-70-0-72-vs-0-72-estimate-sales-1-255b-1-27b-vs-1-27b-e
Benzinga Newsdesk
2019-02-20T00:00:00
A
149
Agilent Technologies Q1 EPS $0.76 Beats $0.73 Estimate, Sales $1.284B Beat $1.27B Estimate
https://www.benzinga.com/news/earnings/19/02/13212600/agilent-technologies-q1-eps-0-76-beats-0-73-estimate-sales-1-284b-beat-
Benzinga Newsdesk
2019-02-20T00:00:00
A
150
10 Stocks To Watch For February 20, 2019
https://www.benzinga.com/news/earnings/19/02/13206712/10-stocks-to-watch-for-february-20-2019
Lisa Levin
2019-02-20T00:00:00
A
151
Earnings Scheduled For February 20, 2019
https://www.benzinga.com/news/earnings/19/02/13206658/earnings-scheduled-for-february-20-2019
Lisa Levin
2019-02-20T00:00:00
A
152
JANA 13F Shows Liquidated Stakes In Alibaba, Agilent, US Steel, SVMK, Electronic Arts, Dollar Tree
https://www.benzinga.com/news/19/02/13174159/jana-13f-shows-liquidated-stakes-in-alibaba-agilent-us-steel-svmk-electronic-art
Benzinga Newsdesk
2019-02-14T00:00:00
A
153
8 Biggest Price Target Changes For Tuesday
https://www.benzinga.com/analyst-ratings/price-target/19/02/13149455/8-biggest-price-target-changes-for-tuesday
Lisa Levin
2019-02-12T00:00:00
A
154
Deutsche Bank Maintains Buy on Agilent Technologies, Raises Price Target to $85
https://www.benzinga.com/news/19/02/13147998/deutsche-bank-maintains-buy-on-agilent-technologies-raises-price-target-to-85
Vick Meyer
2019-02-12T00:00:00
A
155
Agilent Technologies Option Alert: Mar 15 $75 Calls at the Ask: 1000 @ $2.3 vs 33 OI; Earnings 2/20 After Close Ref=$73.74
https://www.benzinga.com/markets/options/19/01/13056183/agilent-technologies-option-alert-mar-15-75-calls-at-the-ask-1000-2-3
Charles Gross
2019-01-29T00:00:00
A
156
Needham Initiates Coverage On Agilent Technologies with Buy Rating, Announces $77 Price Target
https://www.benzinga.com/news/19/01/12924487/needham-initiates-coverage-on-agilent-technologies-with-buy-rating-announces-77-
Vick Meyer
2019-01-03T00:00:00
A
157
50 Biggest Movers From Yesterday
https://www.benzinga.com/news/18/11/12737162/50-biggest-movers-from-yesterday
Lisa Levin
2018-11-21T00:00:00
A
158
36 Stocks Moving In Tuesday's Mid-Day Session
https://www.benzinga.com/news/18/11/12733299/36-stocks-moving-in-tuesdays-mid-day-session
Lisa Levin
2018-11-20T00:00:00
A
159
Shares of Agilent Technologies are trading up 6% after the company beat Q4 Earnings estimates and issued upbeat FY19 guidance.
https://www.benzinga.com/markets/wiim/18/11/12733017/shares-of-agilent-technologies-are-trading-up-6-after-the-company-beat-q
Benzinga Newsdesk
2018-11-20T00:00:00
A
160
Morgan Stanley Maintains Overweight on Agilent Technologies, Raises Price Target to $89
https://www.benzinga.com/news/18/11/12732252/morgan-stanley-maintains-overweight-on-agilent-technologies-raises-price-target-
Vick Meyer
2018-11-20T00:00:00
A
161
26 Stocks Moving In Tuesday's Pre-Market Session
https://www.benzinga.com/news/18/11/12730696/26-stocks-moving-in-tuesdays-pre-market-session
Lisa Levin
2018-11-20T00:00:00
A
162
10 Stocks To Watch For November 20, 2018
https://www.benzinga.com/news/earnings/18/11/12729524/10-stocks-to-watch-for-november-20-2018
Lisa Levin
2018-11-20T00:00:00
A
163
6 Stocks Moving In Monday's After-Hours Session
https://www.benzinga.com/news/18/11/12727689/6-stocks-moving-in-mondays-after-hours-session
Brett Hershman
2018-11-19T00:00:00
A
164
Agilent Sees Q1 Adj. EPS $0.71-$0.73 vs $0.72 Estimate, Sales $1.265B-$1.28B vs $1.27B Est.
https://www.benzinga.com/news/18/11/12726764/agilent-sees-q1-adj-eps-0-71-0-73-vs-0-72-estimate-sales-1-265b-1-28b-vs-1-27b-e
Benzinga Newsdesk
2018-11-19T00:00:00
A
165
Agilent Sees FY19 Adj. EPS $3-$3.05 vs $2.96 Estimate, Sales $5.13B-$5.17B vs $5.18B Est.
https://www.benzinga.com/news/18/11/12726760/agilent-sees-fy19-adj-eps-3-3-05-vs-2-96-estimate-sales-5-13b-5-17b-vs-5-18b-est
Benzinga Newsdesk
2018-11-19T00:00:00
A
166
Agilent Technologies, Inc. Q4 EPS $0.81 Beats $0.74 Estimate, Sales $1.29B Beat $1.25B Estimate
https://www.benzinga.com/news/earnings/18/11/12726755/agilent-technologies-inc-q4-eps-0-81-beats-0-74-estimate-sales-1-29b-be
Benzinga Newsdesk
2018-11-19T00:00:00
A
167
8 Stocks To Watch For November 19, 2018
https://www.benzinga.com/news/earnings/18/11/12721643/8-stocks-to-watch-for-november-19-2018
Lisa Levin
2018-11-19T00:00:00
A
168
Earnings Scheduled For November 19, 2018
https://www.benzinga.com/news/earnings/18/11/12721567/earnings-scheduled-for-november-19-2018
Lisa Levin
2018-11-19T00:00:00
A
169
13F From JANA Shows Cut Stake In Agilent
https://www.benzinga.com/news/18/11/12696733/13f-from-jana-shows-cut-stake-in-agilent
Benzinga Newsdesk
2018-11-14T00:00:00
A
170
Agilent Highlights Letter To SEC Related To Material Misstatements In Twist Bioscience's S-1
https://www.benzinga.com/news/18/10/12584510/agilent-highlights-letter-to-sec-related-to-material-misstatements-in-twist-bios
Benzinga Newsdesk
2018-10-29T00:00:00
A
171
Morgan Stanley Maintains Overweight on Agilent Technologies, Raises Price Target to $86
https://www.benzinga.com/news/18/10/12483208/morgan-stanley-maintains-overweight-on-agilent-technologies-raises-price-target-
Vick Meyer
2018-10-10T00:00:00
A
172
A Peek Into The Markets: US Stock Futures Up; All Eyes On Fed Decision
https://www.benzinga.com/news/18/09/12408628/a-peek-into-the-markets-us-stock-futures-up-all-eyes-on-fed-decision
Lisa Levin
2018-09-26T00:00:00
A
173
Agilent Technologies To Acquire ACEA Biosciences; Financial Terms Not Disclosed
https://www.benzinga.com/news/18/09/12408423/agilent-technologies-to-acquire-acea-biosciences-financial-terms-not-disclosed
Benzinga_Newsdesk
2018-09-26T00:00:00
A
174
Agilent to Acquire ACEA Biosciences for $250M in Cash
https://www.benzinga.com/news/18/09/12408192/agilent-to-acquire-acea-biosciences-for-250m-in-cash
Charles Gross
2018-09-26T00:00:00
A
175
A Life Science Tools And Diagnostics Pair Trade: Goldman Recommends Buying Agilent, Moving to Sidelines On Thermo Fisher
https://www.benzinga.com/analyst-ratings/analyst-color/18/09/12363481/a-life-science-tools-and-diagnostics-pair-trade-goldman
Shanthi Rexaline
2018-09-17T00:00:00
A
176
Agilent Companion Diagnostic Gains Expanded FDA Approval in Urothelial Carcinoma, PD-L1 IHC 22C3 pharmDx Now Approved to Identify Certain Urothelial Carcinoma Patients for Treatment With KEYTRUDA
https://www.benzinga.com/news/18/08/12238386/agilent-companion-diagnostic-gains-expanded-fda-approval-in-urothelial-carcinoma
Benzinga_Newsdesk
2018-08-21T00:00:00
A
177
Deutsche Bank Maintains Buy on Agilent Technologies, Raises Price Target to $80
https://www.benzinga.com/news/18/08/12208991/deutsche-bank-maintains-buy-on-agilent-technologies-raises-price-target-to-80
Vick Meyer
2018-08-15T00:00:00
A
178
30 Stocks Moving In Wednesday's Pre-Market Session
https://www.benzinga.com/news/18/08/12208634/30-stocks-moving-in-wednesdays-pre-market-session
Lisa Levin
2018-08-15T00:00:00
A
179
Morgan Stanley Maintains Overweight on Agilent Technologies, Raises Price Target to $84
https://www.benzinga.com/news/18/08/12208285/morgan-stanley-maintains-overweight-on-agilent-technologies-raises-price-target-
Vick Meyer
2018-08-15T00:00:00
A
180
A Peek Into The Markets: US Stock Futures Tumble Ahead Of Economic Reports
https://www.benzinga.com/news/18/08/12208171/a-peek-into-the-markets-us-stock-futures-tumble-ahead-of-economic-reports
Lisa Levin
2018-08-15T00:00:00
A
181
10 Stocks To Watch For August 15, 2018
https://www.benzinga.com/news/earnings/18/08/12207581/10-stocks-to-watch-for-august-15-2018
Lisa Levin
2018-08-15T00:00:00
A
182
Agilent Technologies Q3 Adj. EPS $0.67 Beats $0.63 Estimate, Sales $1.203B Beat $1.2B Estimate
https://www.benzinga.com/news/earnings/18/08/12205480/agilent-technologies-q3-adj-eps-0-67-beats-0-63-estimate-sales-1-203b-b
Benzinga Newsdesk
2018-08-14T00:00:00
A
183
13F Filing From Tiger Global Shows Dissolved Stake In Activision, Agilent, Altria, and American Express
https://www.benzinga.com/general/hedge-funds/18/08/12203728/13f-filing-from-tiger-global-shows-dissolved-stake-in-activision-
Benzinga Newsdesk
2018-08-14T00:00:00
A
184
Jana Partners 13F shows Increased Stake In Agilent Technologies From ~1.02M Shares To ~1.22M Shares
https://www.benzinga.com/news/18/08/12200786/jana-partners-13f-shows-increased-stake-in-agilent-technologies-from-1-02m-share
Benzinga Newsdesk
2018-08-14T00:00:00
A
185
Agilent Technologies Q3 Earnings Preview
https://www.benzinga.com/news/earnings-previews/18/08/12197068/agilent-technologiess-earnings-preview
Benzinga Newsdesk
2018-08-14T00:00:00
A
186
Earnings Scheduled For August 14, 2018
https://www.benzinga.com/news/earnings/18/08/12197301/earnings-scheduled-for-august-14-2018
Lisa Levin
2018-08-14T00:00:00
A
187
10 Stocks To Watch For August 14, 2018
https://www.benzinga.com/news/earnings/18/08/12197267/10-stocks-to-watch-for-august-14-2018
Lisa Levin
2018-08-14T00:00:00
A
188
Agilent Announces CFO Didier Hirsch To Retire October 31, Robert McMahon To Become CFO
https://www.benzinga.com/news/18/07/12111267/agilent-announces-cfo-didier-hirsch-to-retire-october-31-robert-mcmahon-to-becom
Benzinga Newsdesk
2018-07-31T00:00:00
A
189
Waters Has Limited Upside Potential To Growth Expectations; Janney Steps to The Sidelines
https://www.benzinga.com/analyst-ratings/analyst-color/18/07/12030082/waters-has-limited-upside-potential-to-growth-expectati
Shanthi Rexaline
2018-07-17T00:00:00
A
190
Agilent, Nanyang Technological University Singapore to Develop Novel Approaches for Water Analysis
https://www.benzinga.com/news/18/07/11989733/agilent-nanyang-technological-university-singapore-to-develop-novel-approaches-f
Benzinga Newdesk
2018-07-09T00:00:00
A
191
Agilent Companion Diagnostic Gains Expanded FDA Approval In Cervical Cancer
https://www.benzinga.com/news/18/06/11869095/agilent-companion-diagnostic-gains-expanded-fda-approval-in-cervical-cancer
Benzinga Newsdesk
2018-06-12T00:00:00
A
192
Agilent to Acquire Assets of Ultra Scientific, No Financial Terms Disclosed
https://www.benzinga.com/news/m-a/18/05/11800815/agilent-to-acquire-assets-of-ultra-scientific-no-financial-terms-disclosed
Benzinga Newsdesk
2018-05-30T00:00:00
A
193
Agilent, University of Duisburg-Essen Announce Collaboration Agreement
https://www.benzinga.com/news/contracts/18/05/11772296/agilent-university-of-duisburg-essen-announce-collaboration-agreement
Benzinga Newsdesk
2018-05-24T00:00:00
A
194
Agilent Signs Agreement to Acquire Assets from Young in Scientific Co. Ltd.; Financial Terms Not Disclosed
https://www.benzinga.com/news/m-a/18/05/11761813/agilent-signs-agreement-to-acquire-assets-from-young-in-scientific-co-ltd-fi
Benzinga Newdesk
2018-05-23T00:00:00
A
195
Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week
https://www.benzinga.com/general/biotech/18/05/11744154/pot-stocks-etfs-top-news-and-data-from-the-cannabis-industry-this-wee
Javier Hasse
2018-05-18T00:00:00
A
196
45 Biggest Movers From Yesterday
https://www.benzinga.com/news/18/05/11723622/45-biggest-movers-from-yesterday
Lisa Levin
2018-05-16T00:00:00
A
197
37 Stocks Moving In Tuesday's Mid-Day Session
https://www.benzinga.com/news/18/05/11716776/37-stocks-moving-in-tuesdays-mid-day-session
Lisa Levin
2018-05-15T00:00:00
A
198
Cowen & Co. Upgrades Agilent Technologies to Outperform
https://www.benzinga.com/news/18/05/11715495/cowen-co-upgrades-agilent-technologies-to-outperform
Benzinga Newsdesk
2018-05-15T00:00:00
A
199
Traders Circulating Chatter That Cowen Upgraded Agilent
https://www.benzinga.com/analyst-ratings/upgrades/18/05/11715253/traders-circulating-chatter-that-cowen-upgraded-agilent
Benzinga Newsdesk
2018-05-15T00:00:00
A